Cerner Corporation Receives FDA Clearance for Cerner Bridge Transfusion Administration and Specimen Collections

Published: Jun 28, 2007

KANSAS CITY, Mo.--(BUSINESS WIRE)--Cerner Corp. (Nasdaq: CERN) announced today that Cerner Bridgeâ„¢ Transfusion Administration and Specimen Collections software solution has received U.S. Food and Drug Administration (FDA) 510(k) pre-market notification clearance. Cerner will immediately make this solution available to clients.

Back to news